Results available in 2 to 3 days Molecular Diagnostic Decision Support (MDDS) Molecular diagnostic decision support (MDDS) for precision medicine is a post-analytic analysis of next generation sequencing (NGS) of a patient’s tumor based on individualized mutation data generated by Henry Ford Laboratories. This in-depth crowd-sourced clinical guidance provides interpretation of patient-specific biomarkers that are of biological and clinical relevance to inform medical judgment related to selection of mutation-specific relevant therapies and biomarker-matched clinical trials. Variants of strong clinical significance (Tier 1), variants of potential clinical significance (Tier 2) and variants of uncertain clinical significance (Tier 3) are evaluated. Henry Ford Center for Precision Diagnostics